Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Direkt zur Navigaton springen.
Direkt zum Inhalt springen.

Navigation/Suche

Publikationen

Suchbegriffe: NEUTRALIZING ANTIBODIES, . Treffer: 24

2023

Callegari, I; Schneider, M; Aebischer, V; Voortman, MM; Proschmann, U; Ziemssen, T; Lindberg, R; Fischer-Barnicol, B; Khalil, M; Kappos, L; Kuhle, J; Sanderson, NSR; Derfuss, T Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis.
Ther Adv Neurol Disord. 2023; 16: 17562864221150040 Doi: 10.1177/17562864221150040 [OPEN ACCESS]
PubMed FullText FullText_MUG

Simão, AL; Palma, CS; Izquierdo-Sanchez, L; Putignano, A; Carvalho-Gomes, A; Posch, A; Zanaga, P; Girleanu, I; Henrique, MM; Araújo, C; Degre, D; Gustot, T; Sahuco, I; Spagnolo, E; Carvalhana, S; Moura, M; Fernandes, DA; Banales, JM; Romero-Gomez, M; Trifan, A; Russo, FP; Stauber, R; Berenguer, M; Moreno, C; Gonçalves, J; Cortez-Pinto, H; Castro, RE Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.
JHEP Rep. 2023; 100697 Doi: 10.1016/j.jhepr.2023.100697 [OPEN ACCESS]
PubMed FullText FullText_MUG

2022

Lichtenegger, S; Saiger, S; Hardt, M; Kulnik, S; Wagner, GE; Kleinhappl, B; Assig, K; Zauner, A; Ober, M; Kimpel, J; von, Laer, D; Zatloukal, K; Steinmetz, I Development of a Rapid Live SARS-CoV-2 Neutralization Assay Based on a qPCR Readout.
J Clin Microbiol. 2022; 60(7): e0037622 Doi: 10.1128/jcm.00376-22 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Niedrist, T; Drexler, C; Torreiter, PP; Matejka, J; Strahlhofer-Augsten, M; Kral, S; Riegler, S; Gülly, C; Zurl, C; Kriegl, L; Krause, R; Berghold, A; Steinmetz, I; Schlenke, P; Herrmann, M Longitudinal Comparison of Automated SARS-CoV-2 Serology Assays in Assessing Virus Neutralization Capacity in COVID-19 Convalescent Sera.
Arch Pathol Lab Med. 2022; 146(5):538-546 Doi: 10.5858/arpa.2021-0604-SA
Web of Science PubMed FullText FullText_MUG

2021

Mangge, H; Kneihsl, M; Schnedl, W; Sendlhofer, G; Curcio, F; Domenis, R Immune Responses against SARS-CoV-2-Questions and Experiences.
Biomedicines. 2021; 9(10): Doi: 10.3390/biomedicines9101342 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Pymm, P; Adair, A; Chan, LJ; Cooney, JP; Mordant, FL; Allison, CC; Lopez, E; Haycroft, ER; O'Neill, MT; Tan, LL; Dietrich, MH; Drew, D; Doerflinger, M; Dengler, MA; Scott, NE; Wheatley, AK; Gherardin, NA; Venugopal, H; Cromer, D; Davenport, MP; Pickering, R; Godfrey, DI; Purcell, DFJ; Kent, SJ; Chung, AW; Subbarao, K; Pellegrini, M; Glukhova, A; Tham, WH Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice.
Proc Natl Acad Sci U S A. 2021; 118(19): e2101918118 Doi: 10.1073/pnas.2101918118 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2020

Harrison, N; Grabmeier-Pfistershammer, K; Graf, A; Schwarzinger, I; Aberle, JH; Stiasny, K; Greinix, H; Rabitsch, W; Kalhs, P; Ramharter, M; Burgmann, H; Forstner, C Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipients.
NPJ Vaccines. 2020; 5:67-67 Doi: 10.1038/s41541-020-00215-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2019

Jensen, PEH; Warnke, C; Ingenhoven, K; Piccoli, L; Gasis, M; Hermanrud, C; Fernandez-Rodriguez, BM; Ryner, M; Kramer, D; Link, J; Ramanujam, R; Auer, M; Buck, D; Grummel, V; Bertotti, E; Fissolo, N; Oliver-Martos, B; Nytrova, P; Khalil, M; Guger, M; Rathmaier, S; Sievers-Stober, C; Lindberg, RLP; Hässler, S; Bachelet, D; Aktas, O; Donnellan, N; Lawton, A; Hemmer, B; Havrdova, EK; Kieseier, B; Hartung, HP; Comabella, M; Montalban, X; Derfuss, T; Sellebjerg, F; Dönnes, P; Pallardy, M; Spindeldreher, S; Broët, P; Deisenhammer, F; Fogdell-Hahn, A; Sorensen, PS; ABIRISK Consortium Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study.
J Neuroimmunol. 2019; 326:19-27 Doi: 10.1016/j.jneuroim.2018.11.002
Web of Science PubMed FullText FullText_MUG

2017

Michel, NA; Zirlik, A; Wolf, D CD40L and Its Receptors in Atherothrombosis-An Update.
Front Cardiovasc Med. 2017; 4(3):40-40 Doi: 10.3389/fcvm.2017.00040 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2016

Vieyra-Garcia, PA; Wei, T; Naym, DG; Fredholm, S; Fink-Puches, R; Cerroni, L; Odum, N; O'Malley, JT; Gniadecki, R; Wolf, P STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.
Clin Cancer Res. 2016; 22(13):3328-3339 Doi: 10.1158/1078-0432.CCR-15-1784 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Gneiss, C; Tripp, P; Ehling, R; Khalil, M; Lutterotti, A; Egg, R; Mayringer, I; Künz, B; Berger, T; Reindl, M; Deisenhammer, F Interferon-beta antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies.
J Neuroimmunol. 2006; 174(1-2): 174-179. Doi: 10.1016/j.jneuroim.2006.01.017
Web of Science PubMed FullText FullText_MUG

Gneiss, C; Tripp, P; Reichartseder, F; Egg, R; Ehling, R; Lutterotti, A; Khalil, M; Kuenz, B; Mayringer, I; Reindl, M; Berger, T; Deisenhammer, F Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients.
Mult Scler. 2006; 12(6):731-737 Doi: 10.1177/1352458506070941
Web of Science PubMed FullText FullText_MUG

2005

Kriegshäuser, G; Deutz, A; Kuechler, E; Skern, T; Lussy, H; Nowotny, N Prevalence of neutralizing antibodies to Equine rhinitis A and B virus in horses and man.
Vet Microbiol. 2005; 106(3-4): 293-296. Doi: 10.1016/j.vetmic.2004.12.029
Web of Science PubMed FullText FullText_MUG

2004

Gneiss, C; Reindl, M; Lutterotti, A; Ehling, R; Egg, R; Khalil, M; Berger, T; Deisenhammer, F Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity.
Mult Scler. 2004; 10(5):507-510 Doi: 10.1191/1352458504ms1074oa
Web of Science PubMed FullText FullText_MUG

2001

Rappl, G; Abken, H; Hasselmann, DO; Tilgen, W; Ugurel, S; Reinhold, U The CD7(-) subset of CD4(+) memory T cells is prone to accelerated apoptosis that is prevented by interleukin-15 (IL-15).
Cell Death Differ. 2001; 8(4):395-402 Doi: 10.1038/sj.cdd.4400825 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Rappl, G; Kapsokefalou, A; Heuser, C; Rössler, M; Ugurel, S; Tilgen, W; Reinhold, U; Abken, H Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-alpha.
J Invest Dermatol. 2001; 116(1):102-109 Doi: 10.1046/j.1523-1747.2001.00239.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

1997

Walther, EU; Dang, T; Hartung, HP; Hohlfeld, R Formation of neutralizing antibodies in therapy of multiple sclerosis with interferon beta-1b. Practical procedure in suspected therapeutic failure
Nervenarzt. 1997; 68(12):935-939 Doi: 10.1007/s001150050219
Web of Science PubMed FullText FullText_MUG

1993

Labuda, M; Stünzner, D; Kozuch, O; Sixl, W; Kociánová, E; Schäffler, R; Vırosteková, V Tick-borne encephalitis virus activity in Styria, Austria.
Acta Virol. 1993; 37(2-3):187-190
Web of Science PubMed

Rabinowich, H; Sedlmayr, P; Herberman, RB; Whiteside, TL Response of human NK cells to IL-6 alterations of the cell surface phenotype, adhesion to fibronectin and laminin, and tumor necrosis factor-alpha/beta secretion.
J Immunol. 1993; 150(11): 4844-4855.
Web of Science PubMed

↑ Seitenanfang / Navigation